Page last updated: 2024-10-22

amlodipine and Metabolic Diseases

amlodipine has been researched along with Metabolic Diseases in 2 studies

Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.

Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Athyros, VG1
Katsiki, N1
Karagiannis, A1
Oleĭnikov, VE1
Matrosova, IB1
Gerasimova, AS1
Tomashevskaia, IuA1

Trials

1 trial available for amlodipine and Metabolic Diseases

ArticleYear
[Efficacy and organoprotective action of amlodipine in patients with arterial hypertension with metabolic derangements].
    Kardiologiia, 2008, Volume: 48, Issue:5

    Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Female; Follow-Up Studies; Humans;

2008

Other Studies

1 other study available for amlodipine and Metabolic Diseases

ArticleYear
Cardiovascular risk reduction with combination of anti-atherosclerotic medications in younger and older patients.
    Current medical research and opinion, 2013, Volume: 29, Issue:7

    Topics: Age Factors; Amlodipine; Antihypertensive Agents; Atherosclerosis; Cardiovascular Diseases; Choleste

2013